Coupling of boswellic acid-induced Ca2+ mobilisation and MAPK activation to lipid metabolism and peroxide formation in human leucocytes

被引:36
作者
Altmann, A [1 ]
Poeckel, D [1 ]
Fischer, L [1 ]
Schubert-Zsilavecz, M [1 ]
Steinhilber, D [1 ]
Werz, O [1 ]
机构
[1] Goethe Univ Frankfurt, Inst Pharmaceut Chem, D-60439 Frankfurt, Germany
关键词
boswellic acids; leucocytes; MAPK; Ca2+; reactive oxygen species; lipoxygenase; arachidonic acid;
D O I
10.1038/sj.bjp.0705604
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 We have previously shown that 11-keto boswellic acids (11-keto-BAs), the active principles of Boswellia serrata gum resins, activate p38 MAPK and p42/44(MAPK) and stimulate Ca2+ mobilisation in human polymorphonuclear leucocytes (PMNL). 2 In this study, we attempted to connect the activation of MAPK and mobilisation of Ca2+ to functional responses of PMNL, including the formation of reactive oxygen species (ROS), release of arachidonic acid (AA), and leukotriene (LT) biosynthesis. 3 We found that, in PMNL, 11-keto-BAs stimulate the formation of ROS and cause release of AA as well as its transformation to LTs via 5-lipoxygenase. 4 Based on inhibitor studies, 11-keto-BA-induced ROS formation is Ca2+-dependent and is mediated by NADPH oxidase involving PI 3-K and p42/44(MAPK) signalling pathways. Also, the release of AA depends on Ca2+ and p42/44(MAPK), whereas the pathways stimulating 5-LO are not readily apparent. 5 Pertussis toxin, which inactivates G(i/o) protein subunits, prevents MAPK activation and Ca2+ mobilisation induced by 11-keto-BAs, implying the involvement of a G(i/o) protein in BA signalling. 6 Expanding studies on differentiated haematopoietic cell lines (HL60, Mono Mac 6, BL41-E-95-A) demonstrate that the ability of BAs to activate MAPK and to mobilise Ca2+ may depend on the cell type or the differentiation status. 7 In summary, we conclude that BAs act via G(i/0) protein(s) stimulating signalling pathways that control functional leucocyte responses, in a similar way as chemoattractants, that is, N-formylmethionyl-leucyl-phenylalanine or platelet-activating factor.
引用
收藏
页码:223 / 232
页数:10
相关论文
共 46 条
  • [41] A test system for leukotriene synthesis inhibitors based on the in-vitro differentiation of the human leukemic cell lines HL-60 and Mono Mac 6
    Werz, O
    Schneider, N
    Brungs, M
    Sailer, ER
    Safayhi, H
    Ammon, HPT
    Steinhilber, D
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 356 (04) : 441 - 445
  • [42] Extracellular signal-regulated kinases phosphorylate 5-lipoxygenase and stimulate 5-lipoxygenase product formation in leukocytes
    Werz, O
    Bürkert, E
    Fischer, L
    Szellas, D
    Dishart, D
    Samuelsson, B
    Rådmark, O
    Steinhilber, D
    [J]. FASEB JOURNAL, 2002, 16 (09) : 1441 - +
  • [43] Activation of 5-lipoxygenase by cell stress is calcium independent in human polymorphonuclear leukocytes
    Werz, O
    Bürkert, E
    Samuelsson, B
    Rådmark, O
    Steinhilber, D
    [J]. BLOOD, 2002, 99 (03) : 1044 - 1052
  • [44] Nonredox 5-lipoxygenase inhibitors require glutathione peroxidase for efficient inhibition of 5-lipoxygenase activity
    Werz, O
    Szellas, D
    Henseler, M
    Steinhilber, D
    [J]. MOLECULAR PHARMACOLOGY, 1998, 54 (02) : 445 - 451
  • [45] Werz O, 1996, PHARMAZIE, V51, P893
  • [46] Boswellic acids inhibit glioma growth:: a new treatment option?
    Winking, M
    Sarikaya, S
    Rahmanian, A
    Jödicke, A
    Böker, DK
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2000, 46 (02) : 97 - 103